Blood Glucose MetersIs FDA Ready to Tighten Up Accuracy Standards?By Bill Malone
After a well attended March meeting on blood glucose meters, FDA now has support from stakeholders to work toward a two-track regulatory approach that would distinguish the needs of individuals monitoring diabetes at home versus healthcare professionals maintaining tight glycemic control (TGC) protocols in clinical settings.
A New Definition of Gestational DiabetesWill Revised Diagnostic Criteria Help or Hurt?By Genna Rollins
An international committee has released new recommendations on the diagnosis and classification of gestational diabetes. If healthcare providers accept these guidelines, two to three times more pregnant women could be considered to have the condition.
Array-based Cytogenetic TestingPoised for a Transformative Role in the Lab and Clinical GeneticsBy Bassem A. Bejjani, MD, and Marvin R. Natowicz, MD, PhD
DNA array-based testing has already contributed to advancements in clinical cytogenetics, especially assessment of DNA copy number changes.. As the technology becomes more accessible to labs, it will likely change the way in which cytogenetic abnormalities are diagnosed.
Warfarin Sensitivity Testing Cuts Hospitalization Rates
News from the FDA
Download the entire issue
What Can Labs Expect from Healthcare Reform?
Lab's Role in Detecting Misuse of Pain Medications.